Nervgen Pharma Corp (NGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2008 | 12-2007 | 09-2007 | 06-2007 | 03-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -22,960 | -33,940 | -33,830 | -26,370 | -11,840 |
| Depreciation Amortization | 2,600 | 8,270 | 5,920 | 4,170 | 1,820 |
| Other Working Capital | 12,120 | 620 | -1,290 | -840 | -2,940 |
| Other Operating Activity | 13,780 | -10,200 | -1,370 | 2,520 | 1,210 |
| Operating Cash Flow | $5,540 | $-35,250 | $-30,570 | $-20,520 | $-11,750 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,050 | -2,480 | -1,790 | -1,220 | -740 |
| Net Acquisitions | 0 | -1,970 | -2,030 | -2,000 | -2,000 |
| Other Investing Activity | 1,340 | 7,400 | 2,940 | 10,930 | 4,550 |
| Investing Cash Flow | $290 | $2,950 | $-880 | $7,710 | $1,810 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | -1,010 | 26,320 | 27,380 | 8,560 | 7,540 |
| Financing Cash Flow | $-1,010 | $26,320 | $27,380 | $8,560 | $7,540 |
| Exchange Rate Effect | -100 | 510 | 1,050 | 260 | -40 |
| Beginning Cash Position | 5,800 | 11,260 | 11,260 | 11,260 | 11,260 |
| End Cash Position | 10,520 | 5,800 | 8,230 | 7,280 | 8,810 |
| Net Cash Flow | $4,720 | $-5,450 | $-3,020 | $-3,970 | $-2,450 |
| Free Cash Flow | |||||
| Operating Cash Flow | 5,540 | -35,250 | -30,570 | -20,520 | -11,750 |
| Free Cash Flow | 5,540 | -35,250 | -30,570 | -20,520 | -11,750 |